Calcineurin Inhibitor Alone or in Combination with Mycophenolate Mofetil for Graft-Versus-Host-Disease Prophylaxis in Patients with Acute Myeloid Leukemia Undergoing Transplantation from Matched Unrelated Donors: A Study from the ALWP of the EBMT

被引：0

作者：

Paviglianiti, Annalisa ^{[1
]}

Labopin, Myriam ^{[2
]}

Blaise, Didier ^{[3
]}

Socie, Gerard ^{[4
,5
]}

Bulabois, Claude-Eric ^{[6
]}

Lioure, Bruno ^{[7
]}

Fegueux, Nathalie ^{[8
]}

Gerbitz, Arnim ^{[9
]}

Guillermin, Gaelle ^{[10
]}

Maertens, Johan ^{[11
]}

Chevallier, Patrice ^{[12
]}

Huynh, Anne ^{[13
]}

Turlure, Pascal ^{[14
]}

Deconinck, Eric ^{[15
]}

Forcade, Edouard ^{[16
]}

Nagler, Arnon ^{[17
]}

Mohty, Mohamad ^{[18
,19
,20
]}

机构：

[1] Hop St Antoine, Hematol, Paris, France

[2] Hop St Antoine, Dept Hematol, Paris, France

[3] Inst Paoli Calmettes, Hematol Dept, Marseille, France

[4] Univ Paris 07, Hop St Louis, Hematol Transplantat, Paris, France

[5] INSERM, UMR 1160, Paris, France

[6] Hosp A Michallon, Dept Hematol, Grenoble, France

[7] Strasbourg Hosp, Hematol, Strasbourg, France

[8] CHU Montpellier, Montpellier, France

[9] Charite Univ Med Berlin, Hematol, Berlin, Germany

[10] Univ Hosp, Hematol, Brest, France

[11] Univ Hosp Gasthuisberg, Leuven, Belgium

[12] CHU Nantes, Hematol, Nantes, France

[13] IUCT O, Toulouse, France

[14] Univ Hosp, Hematol, Limoges, France

[15] Jean Minjoz Hosp, Serv Hematol, Besancon, France

[16] Hop Haut Leveque, Hematol Clin & Therapie Cellulaire, Pessac, France

[17] Tel Aviv Univ, Div Hematol & Bone Marrow Transplantat, Chaim Sheba Med Ctr, Ramat Gan, Israel

[18] St Antoine Hosp, Dept Haematol, Paris, France

[19] St Antoine Hosp, EBMT Paris Study Off, CEREST TC, Paris, France

[20] Univ Paris 06, Paris, France

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S56 / S57

页数：2

共 50 条

[21] Graft-Versus-Host Disease Prophylaxis in Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation: Comparing the Efficacy of Mycophenolate Mofetil and Methotrexate in Combination with Calcineurin Inhibitor
Chhabra, Saurabh
Liu, Ying
Hemmer, Michael
Wang, Tao
Hamilton, Betty K.
Costa, Luciano J.
Kim, Dennis D.
Majhail, Navneet S.
Stuart, Robert K.
Alousi, Amin M.
Couriel, Daniel R.
Pidala, Joseph A.
Spellman, Stephen R.
Ringden, Olle
Arora, Mukta
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S170 - S171
[22] Cyclophosphamide with cyclosporine A for graft-versus-host disease prophylaxis in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation from human leucocyte antigen-matched donors
El-Deen, Mustafa O. Sharaf
Soliman, Moetaza M.
Al-Azab, Gamal
Samra, Mohamed
Shams, Mohammad E. E.
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 120
[23] The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors
Yerushalmi, Ronit
Shem-Tov, Noga
Danylesko, Ivetta
Shouval, Roni
Nagler, Arnon
Shimoni, Avichai
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (03) : 259 - 268
[24] The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors
Yerushalmi, Ronit
Shem-Tov, Noga
Danylesko, Ivetta
Nagler, Arnon
Shimoni, Avichai
BLOOD, 2015, 126 (23)
[25] Graft-versus-Host Disease Prophylaxis with PostTransplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
Orti, Guillermo
Gras, Luuk
Koster, Linda
Kulagin, Aleksander
Byrne, Jenny
Apperley, Jane F.
Halaburda, Kazimierz
Blau, Igor Wolfgang
Clark, Andrew
Kroeger, Nicolaus
Griskevicius, Laimonas
Carlson, Kristina
Collin, Matthew
Bloor, Adrian
Raiola, Anna Maria
Blaise, Didier
Aljurf, Mahmoud
Lopez-Corral, Lucia
Sakellari, Ioanna
Beguin, Yves
Wrobel, Tomasz
de Rosa, Luca
de Lavallade, Hughes
Hayden, Patrick J.
McLornan, Donal
Chalandon, Yves
Yakoub-Agha, Ibrahim
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 93.e1 - 93.e12
[26] PROPHYLAXIS WITH MYCOPHENOLATE MOFETIL AND CYCLOSPORINE CAN DECREASE THE INCIDENCE OF SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FROM MATCHED UNRELATED DONORS
Brissot, E.
Chevallier, P.
Delaunay, J.
Guillaume, T.
Ayari, S.
Dubruille, V.
Mahe, B.
Le Gouill, S.
Gastinne, T.
Blin, N.
Moreau, P.
Harousseau, J. L.
Mohty, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 60 - 60
[27] Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT
Shem-Tov, Noga
Peczynski, Christophe
Labopin, Myriam
Itala-Remes, Maija
Blaise, Didier
Labussiere-Wallet, Helene
Socie, Gerard
Kroeger, Nicolaus
Ljungman, Per
Afanasyev, Boris
Chevallier, Patrice
Tischer, Johanna
Helbig, Grzegorz
Jindra, Pavel
Giebel, Sebastian
Mohty, Mohamad
Nagler, Arnon
BLOOD, 2018, 132
[28] Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT
Nagler, Arnon
Labopin, Myriam
Arat, Mutlu
Remenyi, Peter
Koc, Yener
Blaise, Didier
Angelucci, Emanuele
Vydra, Jan
Kulagin, Aleksandr
Socie, Gerard
Rovira, Montserrat
Sica, Simona
Aljurf, Mahmoud
Gulbas, Zafer
Kroger, Nicolaus
Brissot, Eolia
Peric, Zinaida
Giebel, Sebastian
Ciceri, Fabio
Mohty, Mohamad
CANCER, 2022, 128 (22) : 3959 - 3968
[29] Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
Brissot, Eolia
Labopin, Myriam
Stelljes, Matthias
Ehninger, Gerhard
Schwerdtfeger, Rainer
Finke, Juergen
Kolb, Hans-Jochem
Ganser, Arnold
Schaefer-Eckart, Kerstin
Zander, Axel R.
Bunjes, Donald
Mielke, Stephan
Bethge, Wolfgang A.
Milpied, Noel
Kalhs, Peter
Blau, Igor-Woflgang
Kroeger, Nicolaus
Vitek, Antonin
Gramatzki, Martin
Holler, Ernst
Schmid, Christoph
Esteve, Jordi
Mohty, Mohamad
Nagler, Arnon
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
[30] Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
Eolia Brissot
Myriam Labopin
Matthias Stelljes
Gerhard Ehninger
Rainer Schwerdtfeger
Jürgen Finke
Hans-Jochem Kolb
Arnold Ganser
Kerstin Schäfer-Eckart
Axel R. Zander
Donald Bunjes
Stephan Mielke
Wolfgang A. Bethge
Noël Milpied
Peter Kalhs
Igor-Woflgang Blau
Nicolaus Kröger
Antonin Vitek
Martin Gramatzki
Ernst Holler
Christoph Schmid
Jordi Esteve
Mohamad Mohty
Arnon Nagler
Journal of Hematology & Oncology, 10

← 1 2 3 4 5 →